These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20178890)

  • 21. Varenicline for tobacco dependence.
    Tavares AR
    N Engl J Med; 2009 Feb; 360(7):731. PubMed ID: 19222131
    [No Abstract]   [Full Text] [Related]  

  • 22. Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
    Pumariega AJ; Nelson R; Rotenberg L
    CNS Spectr; 2008 Jun; 13(6):511-4. PubMed ID: 18567975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient.
    Anghelescu I
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):102-3. PubMed ID: 19359464
    [No Abstract]   [Full Text] [Related]  

  • 25. Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
    Fatemi SH; Yousefi MK; Kneeland RE; Liesch SB; Folsom TD; Thuras PD
    Schizophr Res; 2013 May; 146(1-3):376-8. PubMed ID: 23507358
    [No Abstract]   [Full Text] [Related]  

  • 26. Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.
    Liu ME; Tsai SJ; Yang ST
    CNS Spectr; 2009 Jul; 14(7):346. PubMed ID: 19773709
    [No Abstract]   [Full Text] [Related]  

  • 27. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study].
    Fagerström KO; Gilljam H; Tonstad S
    Lakartidningen; 2011 Nov 2-8; 108(44):2215-7. PubMed ID: 22165180
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
    Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F
    Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682
    [No Abstract]   [Full Text] [Related]  

  • 31. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
    Franck AJ; Sliter LR
    Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline induced psychosis in schizophrenia.
    Gupta A; Bastiampillai T; Adams M; Nelson A; Nance M
    Aust N Z J Psychiatry; 2012 Oct; 46(10):1009. PubMed ID: 22495951
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
    Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
    Graham DJ; By K; McKean S; Mosholder A; Kornegay C; Racoosin JA; Young J; Levenson M; MaCurdy TE; Worrall C; Kelman JA
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1205-12. PubMed ID: 25044169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of smoking cessation clinic subjects].
    Shino M; Saito H; Takiguchi S; Kushihashi Y; Suzuki M; Yamada Y; Kadokura Y; Kano M; Suzaki H
    Nihon Jibiinkoka Gakkai Kaiho; 2011 Aug; 114(8):721-5. PubMed ID: 21919308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varenicline-associated acute renal failure.
    Bird ML; Vesta KS
    Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More evidence that varenicline harms the heart.
    Harv Ment Health Lett; 2011 Oct; 28(4):7. PubMed ID: 22125830
    [No Abstract]   [Full Text] [Related]  

  • 40. Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
    Forcen FE; Martinez FL; Moya AM
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):221-3. PubMed ID: 22182460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.